Schwartz Investment Counsel Inc. Has $49.71 Million Position in Chemed Corporation $CHE

Schwartz Investment Counsel Inc. lessened its stake in Chemed Corporation (NYSE:CHE) by 20.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 111,033 shares of the company’s stock after selling 28,771 shares during the period. Chemed comprises 1.7% of Schwartz Investment Counsel Inc.’s portfolio, making the stock its 17th biggest holding. Schwartz Investment Counsel Inc.’s holdings in Chemed were worth $49,714,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CHE. Creekmur Asset Management LLC bought a new stake in shares of Chemed in the 2nd quarter worth approximately $28,000. First Horizon Corp acquired a new position in shares of Chemed in the third quarter valued at $31,000. Parkside Financial Bank & Trust raised its stake in shares of Chemed by 86.3% in the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after purchasing an additional 44 shares in the last quarter. HM Payson & Co. lifted its position in Chemed by 35.5% in the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after purchasing an additional 27 shares during the period. Finally, Geneos Wealth Management Inc. boosted its stake in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the sale, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This trade represents a 2.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.29% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CHE. Royal Bank Of Canada dropped their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research note on Monday, November 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Chemed currently has a consensus rating of “Moderate Buy” and a consensus target price of $574.25.

Chemed Stock Performance

Shares of NYSE:CHE opened at $452.40 on Monday. The company’s fifty day moving average is $435.69 and its 200-day moving average is $443.85. Chemed Corporation has a 52 week low of $408.42 and a 52 week high of $623.60. The company has a market capitalization of $6.41 billion, a PE ratio of 23.92, a P/E/G ratio of 2.20 and a beta of 0.44.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.39 by ($0.12). The firm had revenue of $624.90 million for the quarter, compared to the consensus estimate of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the business earned $5.64 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, analysts forecast that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Monday, November 17th were issued a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, November 17th. Chemed’s payout ratio is presently 12.69%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.